fda warning letters glp-1 compounding october 2025 Letter to Fox Corporation regarding misleading Hims & Hers Super Bowl ad – Partnership for Safe Medicines Compounded GLP-1s: Why doctors worry

Side effects are one contributing factor with respect to discontinuation

S.BenedictJ

Verkerk AJ, Pieretti M, Sutcliffe JS, Fu Y-H, Kuhl DP, Pizzuti A, et al

Conditions Being Studied with KPV Peptide Research is currently investigating KPV in: Gastrointestinal Disorders Crohns disease Ulcerative colitis Irritable bowel syndrome (IBS) Leaky gut syndrome Chronic intestinal inflammation Autoimmune Disorders Rheumatoid arthritis Psoriasis Lupus Hashimotos thyroiditis Other inflammatory autoimmune conditions Dermatological Conditions Eczema Atopic dermatitis Rosacea Psoriasis Acne-related inflammation Metabolic and Inflammatory Conditions Obesity-related inflammation Metabolic syndrome Chronic fatigue associated with inflammation Inflammaging (age-related inflammation) KPV and the Gut-Skin-Autoimmune Connection Modern research increasingly recognizes the relationship between: Gut health Immune regulation Skin health Chronic inflammation Inflammation originating in the gut may contribute to: Autoimmune activation Skin disorders Fatigue Brain fog Metabolic dysfunction Because KPV appears to act on both gut inflammation and immune regulation, it has become an area of significant scientific interest

Fulltext Views 330,662 PDF downloads 55,935